Detalhe da pesquisa
1.
Determining Which Patients Require Preoperative Pelvic Radiotherapy Before Curative-Intent Surgery and/or Ablation for Metastatic Rectal Cancer.
Ann Surg Oncol
; 2022 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35377061
2.
Prediction of epithelial-to-mesenchymal transition molecular subtype using CT in gastric cancer.
Eur Radiol
; 32(1): 1-11, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120231
3.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer
; 25(1): 207-217, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34480657
4.
A phase I study of IMC-001, a PD-L1 blocker, in patients with metastatic or locally advanced solid tumors.
Invest New Drugs
; 39(6): 1624-1632, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34268711
5.
Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer.
Oncology
; 99(6): 365-372, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730723
6.
Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
Gastric Cancer
; 24(2): 457-466, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32970267
7.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer
; 24(4): 946-958, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743112
8.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Gastric Cancer
; 23(3): 510-519, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31863227
9.
Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors.
BMC Ophthalmol
; 20(1): 19, 2020 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918686
10.
Bridging genomics and phenomics of gastric carcinoma.
Int J Cancer
; 145(9): 2407-2417, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30801717
11.
Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
Oncology
; 97(1): 38-43, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048579
12.
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 390(10111): 2461-2471, 2017 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28993052
13.
Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line.
BMC Cancer
; 18(1): 1103, 2018 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30419860
14.
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.
Gastric Cancer
; 21(5): 802-810, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29372461
15.
Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.
Oncologist
; 22(10): 1169-1177, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28701572
16.
Phase I trial and pharmacokinetic study of tanibirumab, a fully human monoclonal antibody to vascular endothelial growth factor receptor 2, in patients with refractory solid tumors.
Invest New Drugs
; 35(6): 782-790, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28391576
17.
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy.
BMC Cancer
; 17(1): 211, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28330462
18.
FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.
Mod Pathol
; 29(9): 1095-103, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230412
19.
Phase II trial of dacomitinib in patients with HER2-positive gastric cancer.
Gastric Cancer
; 19(4): 1095-1103, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26581547
20.
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal Cancer.
Mol Ther
; 23(9): 1532-40, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26073886